THISX Holdings — T. Rowe Price Health Sciences Fund, Inc.
All 287 reported holdings of T. Rowe Price Health Sciences Fund, Inc. (THISX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 10.14% | $1.10B |
| Thermo Fisher Scientific, Inc. | 4.07% | $442.86M |
| Intuitive Surgical, Inc. | 3.65% | $397.94M |
| Stryker Corp. | 3.46% | $377.06M |
| Merck & Co. Inc. | 3.44% | $374.87M |
| Astrazeneca PLC | 3.17% | $345.38M |
| Unitedhealth Group, Inc. | 3.09% | $336.31M |
| Argenx SE - ADR | 2.92% | $317.89M |
| Abbvie, Inc. | 2.84% | $309.56M |
| Regeneron Pharmaceuticals | 2.65% | $288.37M |
| Gilead Sciences, Inc. | 2.60% | $283.60M |
| Johnson & Johnson | 2.44% | $266.04M |
| Vertex Pharmaceuticals, Inc. | 2.42% | $264.04M |
| Danaher Corp. | 2.05% | $222.87M |
| Alnylam Pharmaceuticals, Inc. | 1.62% | $175.99M |
| Ascendis Pharma A/s - ADR | 1.42% | $154.66M |
| Revolution Medicines, Inc. | 1.36% | $147.79M |
| United Therapeutics Corp. | 1.34% | $146.43M |
| Beone Medicines Ltd. | 1.19% | $129.16M |
| Roivant Sciences Ltd. | 1.13% | $123.20M |
| Protagonist Therapeutics, Inc. | 1.10% | $120.37M |
| Insmed, Inc. | 1.05% | $114.90M |
| Summit Therapeutics, Inc. | 1.04% | $112.78M |
| Natera, Inc. | 1.03% | $112.34M |
| Tenet Healthcare Corp. | 1.00% | $109.47M |
| Brightspring Health Services | 0.98% | $107.12M |
| Amgen, Inc. | 0.98% | $106.86M |
| Boston Scientific Corp. | 0.92% | $100.64M |
| Hca Healthcare, Inc. | 0.90% | $97.59M |
| Guardant Health, Inc. | 0.90% | $97.54M |
| Cvs Health Corp. | 0.86% | $94.11M |
| Kymera Therapeutics, Inc. | 0.77% | $83.49M |
| Cigna Group/the | 0.74% | $80.11M |
| Cg Oncology, Inc. | 0.69% | $75.03M |
| Cardinal Health, Inc. | 0.68% | $73.58M |
| Elevance Health, Inc. | 0.66% | $71.51M |
| Krystal Biotech, Inc. | 0.65% | $70.64M |
| Scholar Rock Holding Corp. | 0.62% | $67.34M |
| Ionis Pharmaceuticals, Inc. | 0.61% | $66.29M |
| Bridgebio Pharma, Inc. | 0.59% | $64.17M |
| Chugai Pharmaceutical Co. Ltd. | 0.58% | $62.92M |
| Structure Therapeutics, Inc. ADR | 0.56% | $61.37M |
| Praxis Precision Medicines I | 0.56% | $60.99M |
| Celcuity, Inc. | 0.56% | $60.61M |
| Royalty Pharma PLC- Cl A | 0.55% | $59.57M |
| Cencora, Inc. | 0.52% | $56.46M |
| Centessa Pharmaceuticals-ADR | 0.50% | $54.32M |
| Vera Therapeutics, Inc. | 0.46% | $49.72M |
| Nuvalent, Inc.-A | 0.43% | $47.11M |
| Apogee Therapeutics, Inc. | 0.43% | $46.72M |
| Abivax SA-ADR | 0.42% | $45.43M |
| Edwards Lifesciences Corp. | 0.41% | $45.03M |
| Cytokinetics, Inc. | 0.40% | $43.71M |
| Incyte Corp. | 0.40% | $43.37M |
| Spyre Therapeutics Inc | 0.40% | $43.08M |
| Dianthus Therapeutics, Inc. | 0.37% | $40.51M |
| Crinetics Pharmaceuticals In | 0.36% | $39.75M |
| Tenax Therapeutics, Inc. | 0.36% | $39.67M |
| Madrigal Pharmaceuticals, Inc. | 0.36% | $39.12M |
| T. Rowe Price Government Reserve Fund | 0.35% | $37.97M |
| Immunome, Inc. | 0.33% | $36.43M |
| Iqvia Holdings, Inc. | 0.32% | $35.40M |
| Kodiak Sciences, Inc. | 0.32% | $35.13M |
| Caris Life Sciences, Inc. | 0.31% | $34.15M |
| Belite Bio, Inc. - ADR | 0.30% | $33.14M |
| Monte Rosa Therapeutics, Inc. | 0.28% | $30.75M |
| Terns Pharmaceuticals, Inc. | 0.27% | $29.37M |
| Axsome Therapeutics, Inc. | 0.25% | $27.70M |
| Moderna Therapeutics, Inc. | 0.25% | $26.80M |
| National Resilience Sr B Cvt Pfd Stk Pp | 0.24% | $26.35M |
| Alumis, Inc. | 0.24% | $26.19M |
| Beam Therapeutics, Inc. | 0.24% | $26.07M |
| Alignment Healthcare, Inc. | 0.24% | $26.00M |
| West Pharmaceutical Services | 0.22% | $24.47M |
| Sonova Holding AG-Reg | 0.22% | $24.06M |
| Revvity, Inc. | 0.22% | $24.03M |
| Idexx Laboratories, Inc. | 0.22% | $23.91M |
| Oruka Therapeutics, Inc. | 0.21% | $23.35M |
| Oric Pharmaceuticals, Inc. | 0.20% | $22.05M |
| Sionna Therapeutics, Inc. | 0.20% | $21.95M |
| Mbx Biosciences, Inc. | 0.20% | $21.53M |
| Mckesson Corp. | 0.19% | $21.22M |
| Rhythm Pharmaceuticals, Inc. | 0.19% | $21.02M |
| Billiontoone, Inc. Cl A | 0.19% | $20.88M |
| Mirum Pharmaceuticals, Inc. | 0.19% | $20.78M |
| Erasca, Inc. | 0.19% | $20.19M |
| Treeline Bio Ser A-1 Cvt Pfd Stock Pp | 0.18% | $20.00M |
| Immunocore Holdings PLC-ADR | 0.18% | $19.40M |
| Palvella Therapeutics, Inc. | 0.18% | $19.09M |
| Arrowhead Pharmaceuticals, Inc. | 0.17% | $18.89M |
| Nurix Therapeutics, Inc. | 0.17% | $18.83M |
| Rapport Therapeutics, Inc. | 0.17% | $18.81M |
| Generate Biomedicines Inc Lockup Shs PP | 0.17% | $18.41M |
| Vaxcyte, Inc. | 0.17% | $18.28M |
| Cellanome Series A Cvt Pfd Stock Pp | 0.16% | $17.34M |
| Centene Corp. | 0.16% | $17.33M |
| Treeline Bio Ser A Cvt Pfd Stock Pp | 0.16% | $17.27M |
| Bio-Rad Laboratories-A | 0.16% | $16.92M |
| Moonlake Immunotherapeutics | 0.15% | $16.53M |
| Novo-Nordisk A/s-Spons ADR | 0.15% | $16.42M |
| Insitro Ser B Cvt Pfd Pp | 0.15% | $16.16M |
| Wave Life Sciences Ltd. | 0.14% | $15.28M |
| Kestra Medical Technologies | 0.14% | $14.84M |
| Stoke Therapeutics, Inc. | 0.14% | $14.72M |
| Encompass Health Corp. | 0.13% | $14.64M |
| Beone Medicines Ltd.-ADR | 0.13% | $14.62M |
| Immunocore Holdings Cb 2.50% 2/30 | 0.13% | $13.95M |
| Charles River Laboratories | 0.13% | $13.74M |
| Arsenal Biosciences Ser C Cvt Pfd Pp | 0.12% | $13.46M |
| Delfi Diagnostics Sr A Cvt Pfd Stock Pp | 0.12% | $13.40M |
| Celldex Therapeutics, Inc. | 0.12% | $13.40M |
| Tango Therapeutics, Inc. | 0.12% | $13.36M |
| Aktis Oncology Inc. Lockup Shs PP | 0.12% | $12.97M |
| Relay Therapeutics, Inc. | 0.12% | $12.93M |
| Repligen Corp. | 0.12% | $12.81M |
| Bicara Therapeutics, Inc. | 0.12% | $12.78M |
| Cogent Biosciences, Inc. | 0.12% | $12.55M |
| Viatris, Inc. | 0.12% | $12.53M |
| Tarsus Pharmaceuticals, Inc. | 0.11% | $12.34M |
| Endeavor Bio Series B Cvt Pfd Stock Pp | 0.11% | $12.19M |
| Ocular Therapeutix, Inc. | 0.11% | $12.19M |
| Clear Labs Series C Cvt Pfd Pp | 0.11% | $12.12M |
| Disc Medicine, Inc. | 0.11% | $11.93M |
| Tyra Biosciences, Inc. | 0.11% | $11.76M |
| Molina Healthcare, Inc. | 0.10% | $11.42M |
| Sartorius AG-Vorzug Pref | 0.10% | $11.09M |
| Seaport Therapeutics Ser B Cvt Pfd Pp | 0.10% | $11.03M |
| Medpace Holdings, Inc. | 0.10% | $11.01M |
| Replimune Group, Inc. | 0.10% | $10.92M |
| Insitro Ser C Cvt Pfd Pp | 0.10% | $10.76M |
| Galvanize Thera Ser C-2 NV Cvt Pfd Pp | 0.10% | $10.70M |
| Corvus Pharmaceuticals, Inc. | 0.10% | $10.61M |
| Kartos Therapeutics Sr C Cvt Pfd Stk Pp | 0.10% | $10.59M |
| Biohaven Ltd. | 0.10% | $10.39M |
| Cleerly Ser C Cvt Pfd Stk Pp | 0.09% | $10.28M |
| Kardium Inc Ser D-6 CVT Pfd Stock PP | 0.09% | $10.19M |
| Genesis Molecular AI Ser B CVT PFD PP | 0.09% | $10.15M |
| Third Arc Bio Ser A Cvt Pfd Pp | 0.09% | $10.12M |
| Climb Bio Inc | 0.09% | $10.06M |
| Kyverna Therapeutics, Inc. | 0.09% | $9.86M |
| Mirum Pharma 6 month Lockup Shs PP | 0.09% | $9.86M |
| Mirum Pharma 9 month Lockup Shs PP | 0.09% | $9.86M |
| Liquidia Corp. | 0.09% | $9.84M |
| Cullinan Therapeutics Inc | 0.09% | $9.76M |
| Olema Pharmaceuticals, Inc. | 0.09% | $9.68M |
| Pharvaris NV | 0.09% | $9.37M |
| Allogene Therapeutics, Inc. | 0.09% | $9.35M |
| National Resilience Sr C Cvt Pfd Stk Pp | 0.09% | $9.34M |
| Lantheus Holdings, Inc. | 0.09% | $9.27M |
| Denali Therapeutics, Inc. | 0.08% | $8.99M |
| Atrium Therapeutics, Inc. | 0.08% | $8.91M |
| Obsidian Therapeutic Sr C Cvt Pfd Stk Pp | 0.08% | $8.82M |
| Shattuck Labs, Inc. | 0.08% | $8.79M |
| Kailera Therapeutics SER B CVT PFD PP | 0.08% | $8.77M |
| Ideaya Biosciences, Inc. | 0.08% | $8.63M |
| Sensorion SA | 0.07% | $8.05M |
| Kardium Inc Series D-7 CVT PFD Stock PP | 0.07% | $7.80M |
| Nchroma Bio Ser I Cvt Pfd Stock Pp | 0.07% | $7.68M |
| Spyglass Pharma, Inc. | 0.07% | $7.53M |
| Delfi Diagnostics Sr B Cvt Pfd Stock Pp | 0.07% | $7.25M |
| Kardium, Inc. Ser D-5 Cvt Pfd Stock Pp | 0.07% | $7.25M |
| Procept Biorobotics Corp. | 0.07% | $7.24M |
| Iovance Biotherapeutics, Inc. | 0.07% | $7.19M |
| Avalyn Pharma Ser C-1 Cvt Pfd Stock Pp | 0.06% | $6.72M |
| Viridian Therapeutics, Inc. | 0.06% | $6.73M |
| Scribe Thera Ser B Cvt Pfd Stock Pp | 0.06% | $6.22M |
| Parabilis Med, Inc. Ser F Cvt Pfd Pp | 0.06% | $6.13M |
| Alto Neuroscience, Inc. | 0.06% | $6.03M |
| Inspire Medical Systems, Inc. | 0.06% | $5.99M |
| Aktis Oncology, Inc. | 0.05% | $5.97M |
| Color Health Sr D-1 Cvt Pfd Stock Pp | 0.05% | $5.91M |
| Element Biosciences Ser C Cvt Pfd Stock Pp | 0.05% | $5.91M |
| Color Health Sr D Cvt Pfd Stock Pp | 0.05% | $5.70M |
| Evommune, Inc. | 0.05% | $5.66M |
| Galvanize Therapeutics Ser C CVT PFD PP | 0.05% | $5.44M |
| Immatics NV | 0.04% | $4.87M |
| Xencor, Inc. | 0.04% | $4.57M |
| Freenome Holdings Ser B Cvt Pfd Pp | 0.04% | $4.55M |
| Parabilis Med, Inc. Ser D Cvt Pfd Stock Pp | 0.04% | $4.47M |
| Kardium Inc Series D-8 CVT PFD Stock PP | 0.04% | $4.39M |
| Deepsight Tech Inc SER C CVT PFD PP | 0.04% | $4.38M |
| SPAC PCSC Freenome PIPE COMMIT PP | 0.04% | $4.33M |
| Genesis Molecular AI Ser A CVT PFD PP | 0.04% | $4.24M |
| Entrada Therapeutics, Inc. | 0.04% | $4.15M |
| Crescent Biopharma, Inc. | 0.04% | $4.06M |
| Zai Lab Ltd. ADR | 0.04% | $4.01M |
| Eikon Therapeutics, Inc Lockup Shs PP | 0.04% | $3.93M |
| Parabilis Med, Inc. Ser E Cvt Pfd Stock Pp | 0.04% | $3.84M |
| Tectonic Therapeutic, Inc. | 0.03% | $3.78M |
| Eikon Therapeutics, Inc. | 0.03% | $3.69M |
| Manus Bio, Inc. Series One-6 Cvt Pfd Pp | 0.03% | $3.67M |
| Parabilis Med, Inc. Ser C Cvt Pfd Stock Pp | 0.03% | $3.62M |
| Tessera Therapeutics Ser C' Cvt Pfd Pp | 0.03% | $3.49M |
| Bicycle Therapeutics PLC-ADR | 0.03% | $3.43M |
| Generate Biomedicines, Inc. | 0.03% | $3.32M |
| Immuneering Corp. - Class A | 0.03% | $3.29M |
| Endeavor Bio Ser C Cvt Pfd Pp | 0.03% | $3.20M |
| Galvanize Thera Ser C-1 Cvt Pfd Pp | 0.03% | $3.17M |
| BridgeBio Oncology Therapeutics Inc | 0.03% | $2.98M |
| Immix Biopharma, Inc. | 0.03% | $2.97M |
| Kartos Therapeutics SR D CVT PFD STK PP | 0.03% | $2.90M |
| Arbor Bio Series B Cvt Pfd Stock Pp | 0.03% | $2.83M |
| Evommune, Inc. Pipe Pp | 0.03% | $2.74M |
| Freenome Holdings Ser C Cvt Pfd Pp | 0.02% | $2.71M |
| Lumicks Tech Ser D Cvt Pfd Stock Pp | 0.02% | $2.67M |
| Dna Script Series C Cvt Pfd Stock Pp | 0.02% | $2.61M |
| Pax Labs Class A Common Pp | 0.02% | $2.60M |
| Agios Pharmaceuticals, Inc. | 0.02% | $2.38M |
| Saluda Medical, Inc. | 0.02% | $2.28M |
| Mirum Pharma Indemnity Holdback Shs PP | 0.02% | $2.21M |
| Treeline Bio SER A-2 CVT PFD PP | 0.02% | $2.18M |
| Enliven Therapeutics, Inc. | 0.02% | $2.11M |
| Saluda Medical Inc Lockup Shs CDI PP | 0.02% | $2.10M |
| Immunovant, Inc. | 0.02% | $2.02M |
| Hims & Hers Health, Inc. | 0.02% | $2.03M |
| Tessera Therapeutics Ser D Cvt Pfd Pp | 0.02% | $1.98M |
| Monopar Therapeutics, Inc. | 0.02% | $1.89M |
| Color Health Series E Cvt Pfd Stock Pp | 0.02% | $1.81M |
| Odyssey Therapeutics Sr B Cvt Pfd Stk Pp | 0.02% | $1.76M |
| Delfi Diagnostics CVT Prom Note PP | 0.02% | $1.73M |
| Arbor Bio Series C Cvt Pfd Stock Pp | 0.02% | $1.71M |
| Sail Biomedicines Ser B Cvt Pfd Stock Pp | 0.02% | $1.68M |
| Rocket Pharmaceuticals, Inc. | 0.02% | $1.66M |
| Cabaletta Bio, Inc. | 0.01% | $1.64M |
| Element Biosciences Ser D Cvt Pfd Pp | 0.01% | $1.56M |
| Element Biosciences Ser D-1 Cvt Pfd Pp | 0.01% | $1.56M |
| Freenome Holdings Ser D Cvt Pfd Pp | 0.01% | $1.54M |
| Adlai Nortye Ltd.-ADR | 0.01% | $1.52M |
| Aura Biosciences, Inc. | 0.01% | $1.48M |
| Ring Therapeutics, Inc. Pp | 0.01% | $1.34M |
| Avalyn Pharma Ser D Cvt Pfd Stock Pp | 0.01% | $1.33M |
| Lenz Therapeutics, Inc. | 0.01% | $1.32M |
| Verily Life Sciences LLC Ser B Units Pp | 0.01% | $1.27M |
| Clear Labs Ser D Cvt Pfd Stock Pp | 0.01% | $1.18M |
| Beta Bionics, Inc. | 0.01% | $1.13M |
| Mirum Pharma Escrow Indemnity PP | 0.01% | $1.13M |
| Radnet, Inc. | 0.01% | $1.01M |
| Mediwound Ltd. | 0.01% | $1.00M |
| Annexon, Inc. | 0.01% | $978.46K |
| Honor Technology Ser D Cvt Pfd Pp | 0.01% | $939.28K |
| Capsule Corp. Series E Cvt Pfd Stock Pp | 0.01% | $915.72K |
| Capsule Corp. Series 1-D Cvt Pfd Stock | 0.01% | $861.75K |
| Nuvation Bio, Inc. | 0.01% | $800.15K |
| Kartos Therapeutics CVT Prom Note PP | 0.01% | $741.02K |
| Odyssey Therapeutics SER D CVT Pfd Stk PP | 0.01% | $668.94K |
| Profoundbio Escrow Fund Payment Pp | 0.01% | $669.26K |
| Reflexion Med CVT Note issued 072525 PP | 0.01% | $656.77K |
| Reflexion Med CVT Note issued 081325 PP | 0.01% | $651.98K |
| Reflexion Med CVT Note issued 082725 PP | 0.01% | $647.18K |
| Honor Technology Ser E Cvt Pfd Stock Pp | 0.01% | $628.74K |
| Freenome Holdings Ser F Cvt Pfd Pp | 0.00% | $521.73K |
| Revolution Medicines, Inc. Wts 12/26 | 0.00% | $345.40K |
| Cabaletta Bio Common WTS 09/26 PP | 0.00% | $321.93K |
| Treeline Bio Common WTS 8/35 PP | 0.00% | $327.31K |
| Janux Therapeutics, Inc. | 0.00% | $314.13K |
| Chromacode INC SER AA CVT PFD STK PP | 0.00% | $178.32K |
| Odyssey Therapeutics Sr C Cvt Pfd Stk Pp | 0.00% | $159.38K |
| Ginkgo Bioworks Holdings, Inc. | 0.00% | $144.36K |
| PROGNOMIQ INC CL A Common PP | 0.00% | $91.00K |
| Mirum Pharma Escrow Expense Fund PP | 0.00% | $45.69K |
| Mirum Pharma Escrow Working Capital PP | 0.00% | $45.69K |
| Affinivax Expense Fund Pp | 0.00% | $11.56K |
| Profoundbio Expense Fund Payment Pp | 0.00% | $470 |
| Ginkgo Bioworks Hlds Ern Out Sh 800 Pp | 0.00% | $0 |
| Chromacode, Inc. Pp | 0.00% | $3.03K |
| Reflexion Medical, Inc. Cvt Pfd Sr E-X Pp | 0.00% | $2.60K |
| Reflexion Medical, Inc. Cvt Pfd Sr C-X Pp | 0.00% | $3.26K |
| Blue Marlin Therapeutics Common Stock PP | 0.00% | $180 |
| Gyroscope Therapeutics Mlstne Pymt 1 Pp | 0.00% | $0 |
| Affinivax Afx3772 Milestone Event Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 700 Pp | 0.00% | $0 |
| Saluda Med Common WTS 3/26 PP | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 2 Pp | 0.00% | $0 |
| Ginkgo Bioworks Hlds Ern Out Shs 600 Pp | 0.00% | $0 |
| Exact Sciences Fda Milestone Pp | 0.00% | $0 |
| Somalogic, Inc. Wts 8/26 | 0.00% | $0 |
| Gyroscope Therapeutics Mlstne Pymt 3 Pp | 0.00% | $0 |
| Generation Bio Co. | 0.00% | $0 |
| Genedx Holdings Corp. Wts 7/26 | 0.00% | $1.65K |
| Mirum Pharma Milestone $750 mil PP | 0.00% | $0 |
| Nutcracker Thera Ser C Cvt Pfd Stock Pp | 0.00% | $0 |
| Reflexion Medical Ser F Cvt Pfd Stock Pp | 0.00% | $1.79K |
| Exact Sciences Cmo Milestone Pp | 0.00% | $0 |
| Odyssey Therapeutics Warrants 6/32 WRT PP | 0.00% | $0 |
| Reflexion Medical, Inc. Cvt Pfd Sr D-X Pp | 0.00% | $1.46K |
| Affinivax Next Gen Prod Mileston Evnt Pp | 0.00% | $0 |
| Mirum Pharma Milestone $500 mil PP | 0.00% | $0 |
THISX overview: performance, fees, allocation and SEC filings